To further validate our hypothesis, we downregulated endoglin expression both in vivo and in vitro and discovered that inhibition of endoglin partially reversed PF, suggesting that endoglin-targeting therapy may be effective in the treatment of PF. Here, ENG is linked to pemphigus foliaceus.